4.7 Article

Modeling the Potential Distribution of Picea chihuahuana Martinez, an Endangered Species at the Sierra Madre Occidental, Mexico

Journal

FORESTS
Volume 6, Issue 3, Pages 692-707

Publisher

MDPI
DOI: 10.3390/f6030692

Keywords

-

Categories

Funding

  1. PRODEP (Programa de Estimulos al Desempeno Academico) as part of the SEP (Secretaria de Educacion Publica-Subsecretaria de Educacion Superior-Direccion General de Educacion Superior Universitaria) through the RED SIERRA MADRE OCCIDENTAL [08-2011-0036]

Ask authors/readers for more resources

Species distribution models (SDMs) help identify areas for the development of populations or communities to prevent extinctions, especially in the face of the global environmental change. This study modeled the potential distribution of the tree Picea chihuahuana Martinez, a species in danger of extinction, using the maximum entropy modeling method (MaxEnt) at three scales: local, state and national. We used a total of 38 presence data from the Sierra Madre Occidental. At the local scale, we compared MaxEnt with the reclassification and overlay method integrated in a geographic information system. MaxEnt generated maps with a high predictive capability (AUC > 0.97). The distribution of P. chihuahuana is defined by vegetation type and minimum temperature at national and state scales. At the local scale, both models calculated similar areas for the potential distribution of the species; the variables that better defined the species distribution were vegetation type, aspect and distance to water flows. Populations of P. chihuahuana have always been small, but our results show potential habitat greater than the area of the actual distribution. These results provide an insight into the availability of areas suitable for the species' regeneration, possibly through assisted colonization.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Impact ofDNAdamage repair defects and aggressive variant features on response to carboplatin-based chemotherapy in metastatic castration-resistant prostate cancer

Peter H. J. Slootbeek, Marleen L. Duizer, Maarten J. van Der Doelen, Iris S. H. Kloots, Malou C. P. Kuppen, Hans M. Westgeest, Carin A. Uyl-de Groot, Samhita Pamidimarri Naga, Marjolijn J. L. Ligtenberg, Inge M. van Oort, Winald R. Gerritsen, Jack A. Schalken, Leonie I. Kroeze, Haiko J. Bloemendal, Niven Mehra

Summary: Platinum-based chemotherapy is not the standard treatment for metastatic castration-resistant prostate cancer patients. This study found that patients with BRCA2 mutations had meaningful responses to carboplatin, suggesting a potential role for both PARPi and platinum-based chemotherapy in preselected mCRPC patients. Despite the poor prognosis for AVPC patients, they showed comparable responses to non-AVPC patients in terms of overall survival and treatment response.

INTERNATIONAL JOURNAL OF CANCER (2021)

Letter Medical Laboratory Technology

Effect of Pneumatic Tube System Transport on Cell-Free DNA

Maartje J. Geerlings, Lisa S. M. Hofste, Eveline J. Kamping, Zumaya Abdi, Sofie H. Tolmeijer, Linda M. Garms, Bastiaan R. Klarenbeek, Marjolijn J. L. Ligtenberg

CLINICAL CHEMISTRY (2021)

Editorial Material Gastroenterology & Hepatology

Multifocal Colorectal Cancer-Do Intraluminal Metastases Occur?

Femke Simmer, Ragna L. A. van der Linden, Marjolijn J. L. Ligtenberg, Bauke Ylstra, Rachel S. van der Post, Iris D. Nagtegaal

GASTROENTEROLOGY (2021)

Article Oncology

Impact of DNA damage repair defects on response to PSMA radioligand therapy in metastatic castration-resistant prostate cancer

Bastiaan M. Prive, Peter H. J. Slootbeek, Babette Laarhuis, Samhita Pamidimarri Naga, Maarten J. van Der Doelen, Ludwike W. M. van Kalmthout, Bart de Keizer, Samer Ezziddin, Clemens Kratochwil, Alfred Morgenstern, Frank Bruchertseifer, Marjolijn J. L. Ligtenberg, J. Alfred Witjes, Inge M. van Oort, Martin Gotthardt, Sandra Heskamp, Marcel J. R. Janssen, Winald R. Gerritsen, James Nagarajah, Niven Mehra

Summary: This study found that in mCRPC patients undergoing DDR gene testing and receiving PSMA-RLT treatment, tumors with DDR abnormalities do not necessarily show better treatment responses.

PROSTATE CANCER AND PROSTATIC DISEASES (2022)

Article Oncology

Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer

Peter H. J. Slootbeek, Iris S. H. Kloots, Minke Smits, Inge M. van Oort, Winald R. Gerritsen, Jack A. Schalken, Marjolijn J. L. Ligtenberg, Katrien Grunberg, Leonie Kroeze, Haiko J. Bloemendal, Niven Mehra

Summary: The study found that almost half of advanced prostate cancer patients receive recommendations for genetically matched therapies, with over 40% of them showing durable responses to the treatment. These findings support the routine referral of selected prostate cancer patients to molecular tumour boards.

BRITISH JOURNAL OF CANCER (2022)

Article Pathology

Nationwide evaluation of mutation-tailored anti-EGFR therapy selection in patients with colorectal cancer in daily clinical practice

Elisabeth M. P. Steeghs, Geraldine R. Vink, Marloes A. G. Elferink, Quirinus J. M. Voorham, Hans Gelderblom, Iris D. Nagtegaal, Katrien Grunberg, Marjolijn J. L. Ligtenberg

Summary: The study in the Netherlands showed an increase in mutation testing rates for CRC patients over time, with anti-EGFR therapy mainly used in KRAS/NRAS wild-type patients after the third treatment line. The national average mutation rate was 63.9%, and NGS-based approaches detected more potential biomarkers.

JOURNAL OF CLINICAL PATHOLOGY (2022)

Article Pathology

Mismatch repair deficiency in early-onset duodenal, ampullary, and pancreatic carcinomas is a strong indicator for a hereditary defect

Valentyna Kryklyva, Lodewijk A. A. Brosens, Monica A. J. Marijnissen-van Zanten, Marjolijn J. L. Ligtenberg, Iris D. Nagtegaal

Summary: The prevalence of dMMR in early-onset duodenal, ampullary, and pancreatic carcinomas was explored, with duodenal carcinomas showing the highest prevalence and most being associated with hereditary cancer syndromes. Universal dMMR testing is recommended in all early-onset duodenal, ampullary, and pancreatic carcinomas to determine the underlying hereditary condition.

JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2022)

Correction Oncology

Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer (vol 126, pg 907, 2022)

Peter H. J. Slootbeek, Iris S. H. Kloots, Minke Smits, Inge M. van Oort, Winald R. Gerritsen, Jack A. Schalken, Marjolijn J. L. Ligtenberg, Katrien Grunberg, Leonie I. Kroeze, Haiko J. Bloemendal, Niven Mehra

BRITISH JOURNAL OF CANCER (2022)

Article Oncology

Healthcare professionals' perspectives on implementation of universal tumor DNA testing in ovarian cancer patients: multidisciplinary focus groups

Vera M. Witjes, Joze C. C. Braspenning, Nicoline Hoogerbrugge, Yvonne H. C. M. Smolders, Dorien M. A. Hermkens, Marian J. E. Mourits, Marjolijn J. L. Ligtenberg, Margreet G. E. M. Ausems, Joanne A. de Hullu

Summary: Universal tumor DNA testing in epithelial ovarian cancer patients can serve as an efficient pre-screening tool for hereditary cancer testing and guide treatment choices. However, implementing the Tumor-First workflow requires optimal multidisciplinary collaboration and detailed standardization.

FAMILIAL CANCER (2023)

Article Plant Sciences

GERMINATION PATTERNS ON GRASSES PRESENT AT THE CHIHUAHUAN DESERT

Obed G. Gutierrez-Gutierrez, Otilia Rivero-Hernandez, Jose Humberto Vega-Mares, Alicia Melgoza-Castillo

Summary: This study investigated the germination characteristics of 24 grass species and found that several species have the potential for rapid establishment in arid zones, including Eragrostis curvula, Bouteloua curtipendula, Leptochloa dubia, and Digitaria californica. However, invasive species E. lehmanniana and Melinis repens may have other strategies to facilitate their establishment.

BOTANICAL SCIENCES (2022)

Article Oncology

Identification of Fusion Genes and Targets for Genetically Matched Therapies in a Large Cohort of Salivary Gland Cancer Patients

Gerben Lassche, Sjoerd van Helvert, Astrid Eijkelenboom, Martijn J. H. Tjan, Erik A. M. Jansen, Patricia H. J. van Cleef, Gerald W. Verhaegh, Eveline J. Kamping, Katrien Grunberg, Adriana C. H. van Engen-van Grunsven, Marjolijn J. L. Ligtenberg, Carla M. L. van Herpen

Summary: This research aimed to assess the prevalence of actionable aberrations in salivary gland cancer (SGC) and identified several new gene fusions. Targets for genetically matched therapies were found in different SGC subtypes. This highlights the potential importance of molecular diagnostics in selecting systemic treatment for SGC.

CANCERS (2022)

Article Oncology

Circulating Tumor DNA-Based Disease Monitoring of Patients with Locally Advanced Esophageal Cancer

Lisa S. M. Hofste, Maartje J. Geerlings, Daniel von Rhein, Sofie H. Tolmeijer, Marjan M. Weiss, Christian Gilissen, Tom Hofste, Linda M. Garms, Marcel J. R. Janssen, Heidi Rutten, Camiel Rosman, Rachel S. van der Post, Bastiaan R. Klarenbeek, Marjolijn J. L. Ligtenberg

Summary: Ultradeep sequencing-based detection of circulating tumor DNA in preoperative plasma of patients with locally advanced esophageal cancer can predict which patients have a high risk of recurrence after neoadjuvant chemoradiotherapy and surgery.

CANCERS (2022)

Article Oncology

Microsatellite instability in noncolorectal and nonendometrial malignancies in patients with Lynch syndrome

Lisa Elze, Rachel S. van der Post, Janet R. Vos, Arjen R. Mensenkamp, Mirjam S. C. de Hullu, Iris D. Nagtegaal, Nicoline Hoogerbrugge, Richarda M. de Voer, Marjolijn J. L. Ligtenberg

Summary: This study aims to assess whether other tumor types in individuals with Lynch syndrome share characteristics similar to colorectal and endometrial carcinomas. Analysis of the tumor history of 1745 individuals with Lynch syndrome revealed that more than half of the malignant tumors, apart from colorectal and endometrial carcinomas, exhibit microsatellite instability (MSI-H) and mismatch repair-deficiency (dMMR). Therefore, MSI-H/dMMR testing should be conducted for all malignancies in patients with Lynch syndrome when considering therapy with immune checkpoint inhibitors.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Article Oncology

PARPing up the right tree; an overview of PARP inhibitors for metastatic castration-resistant prostate cancer

Peter H. J. Slootbeek, Joanneke K. Overbeek, Marjolijn J. L. Ligtenberg, Nielka P. van Erp, Niven Mehra

Summary: PARP inhibitors have shown great potential in the treatment of metastatic castration-resistant prostate cancer, with superior responses observed in patients with BRCA1 or BRCA2 gene mutations. Combination therapy with androgen receptor signaling inhibitors can prolong progression-free survival in HRRm patients, but has limited efficacy in the non-HRRm subgroup.

CANCER LETTERS (2023)

Article Oncology

Cost-Effectiveness of Parallel Versus Sequential Testing of Genetic Aberrations for Stage IV Non-Small-Cell Lung Cancer in the Netherlands

Henri B. Wolff, Elisabeth M. P. Steeghs, Zakile A. Mfumbilwa, Harry J. M. Groen, Eddy M. Adang, Stefan M. Willems, Katrien Grunberg, Ed Schuuring, Marjolijn J. L. Ligtenberg, Bastiaan B. J. Tops, Veerle M. H. Coupe

Summary: This study evaluates the efficacy of parallel next generation sequencing (NGS)-based testing compared to sequential single-gene-based testing in patients with stage IV nonsquamous non-small-cell lung cancer. The results show that parallel testing is cheaper and more effective than sequential testing, with the ability to detect additional relevant genetic aberrations.

JCO PRECISION ONCOLOGY (2022)

No Data Available